J&J files for authorization of COVID-19 vaccine booster

  • 📰 YahooSG
  • ⏱ Reading Time:
  • 47 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 71%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

J&J said its submission includes data from a late-stage study that found a booster given 56 days after the primary dose provided 94% protection against symptomatic COVID-19 in the United States and 100% protection against severe disease, at least 14 days after the booster shot. While scientists are divided over the need for booster shots when so many people in the United States and other countries remain unvaccinated, the Biden administration announced the push for an extra dose in August to shore up protection against the highly transmissible Delta variant. J&J's filing comes after the FDA last week scheduled an Oct. 15 meeting of its expert advisory committee to discuss whether to authorize a second shot of the company's single-dose vaccine.

FILE PHOTO: Vials and medical syringe are seen in front of J&J logo in this illustration

J&J said its submission includes data from a late-stage study that found a booster given 56 days after the primary dose provided 94% protection against symptomatic COVID-19 in the United States and 100% protection against severe disease, at least 14 days after the booster shot. J&J's filing comes after the FDA last week scheduled an Oct. 15 meeting of its expert advisory committee to discuss whether to authorize a second shot of the company's single-dose vaccine.The FDA has already authorized a booster dose of the vaccine developed by Pfizer Inc and partner BioNTech for 65-year olds and older, people at high risk of severe disease and others who are regularly exposed to the virus.

Rival vaccine maker Moderna also submitted an application seeking authorization for a booster shot of its two-dose vaccine last month, and an FDA panel will hold a meeting on Oct. 14 to discuss the extra dose.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Thailand in talks with Merck for 200,000 courses of anti-COVID-19 pillsBANGKOK: Thailand\u0027s government is in talks with US drugmaker Merck to purchase 200,000 courses of the company\u0027s experimental antiviral pill for COVID-19 treatment, a Thai official said on Monday (Oct 4). Many Asian countries are scrambling to lock in supplies of the potential treatment early after they lag DOHgovph Tayo po?
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

ICU bed occupancy rises to 53% amid 'exponential rise' in COVID-19 casesSINGAPORE: Bed occupancy in the intensive care units (ICU) of public hospitals has risen from 26 per cent to 53 per cent over the last three months, said Senior Minister of State for Health Janil Puthucheary in Parliament on Monday (Oct 4). It is one of the ways in which the recent \u0022exponential rise\u0022 in CO So in other words we were caught pants down due to exponential rise in covid cases and were not prepared for them? Complacency? Bad planing again
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Malaysia to allow use of different COVID-19 vaccines as booster jabs: Health ministerKUALA LUMPUR: The Malaysian government will proceed with a heterologous vaccination plan for COVID-19 booster shots, which uses a vaccine different from the original vaccine received by the individual, said Health Minister Khairy Jamaluddin on Monday (Oct 4). Responding to a question by Beaufort Memb
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »